NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Overview Fund Activity
Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

29 hedge funds and large institutions have $991K invested in NeuBase Therapeutics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
-4
Holders Change %
-12.12%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
3
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
$285K
2
LCM
Leisure Capital Management
California
$12K
3
VF
Virtu Financial
New York
$35K
4
UBS Group
UBS Group
Switzerland
$7K
5
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
$2K

Top Sellers

1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$0
2
Group One Trading
Group One Trading
Illinois
$0
3
Citadel Advisors
Citadel Advisors
Florida
$3K
4
GBA
Garrison Bradford & Associates
New York
$76K
5
FNBT
FineMark National Bank & Trust
Florida
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
FNBT
26
FineMark National Bank & Trust
Florida
– -$4K -56 Closed
State Street
27
State Street
Massachusetts
– -$2K -26 Closed
Janney Montgomery Scott
28
Janney Montgomery Scott
Pennsylvania
– -$2K -26 Closed
JPMorgan Chase & Co
29
JPMorgan Chase & Co
New York
– -$1K -7 Closed
1
2